TLDR: Caylent, an AWS Premier Tier Services Partner, has renewed its Strategic Collaboration Agreement with Amazon Web Services. This expanded partnership focuses on accelerating enterprise cloud adoption and generative AI (GenAI) enablement across various high-growth industries, including healthcare, financial services, and media. The agreement includes the launch of 16 new industry-tailored GenAI solutions and the expansion of Caylent’s AI-focused teams.
NEW YORK – July 16, 2025 – Caylent, a leading Amazon Web Services (AWS) Premier Tier Services Partner, today announced the renewal of its Strategic Collaboration Agreement (SCA) with AWS. This significant expansion of their partnership is set to bolster investment in artificial intelligence (AI) and industry-specific solutions, aiming to accelerate enterprise cloud adoption and the integration of generative AI (GenAI) across a diverse range of high-growth sectors.
The renewed agreement targets key verticals including healthcare and life sciences, financial services, media and entertainment, sports, Software as a Service (SaaS) and Independent Software Vendors (ISVs), travel and hospitality, energy, automotive and manufacturing, and education technology. A core component of this collaboration is the launch of 16 new industry-tailored GenAI solutions, designed to address specific challenges and opportunities within these sectors.
To support this initiative, Caylent is significantly expanding its industry and AI-focused teams, notably through the creation of new Industry Principal Strategists. These domain experts will leverage their deep understanding of unique regulatory, operational, and data challenges within each vertical to guide customers through complex modernization processes, providing tailored roadmaps and measurable outcomes.
Among the first four GenAI solutions to be launched are:
Intelligent Document Processing for Financial Services: This solution transforms financial documents into actionable insights using AI pipelines that automate intake, extraction, and regulatory compliance.
Video Understanding for Media & Entertainment: Designed to convert video content into strategic insights, this AI-powered tool analyzes visuals, audio, and text to enhance personalization, engagement, and monetization efforts.
Clinical Trial Design Optimizer: This solution aims to bring precision and speed to clinical trial design by integrating real-world data, AI insights, and regulatory precedents. It is projected to cut trial execution costs by 10-20% and accelerate overall development timelines by 5-10%.
Clinical Document Writer: This tool automates clinical writing with AI, promising to reduce regulatory submission documentation time by 40% and costs by 50%.
Val Henderson, Caylent President and Chief Revenue Officer, emphasized the strategic importance of this renewed partnership. “As an all-in AWS Premier Tier Services Partner, we’re proud to be launching new, purpose-built GenAI solutions across high-growth industries that solve real-world problems,” said Henderson. “By adding experienced industry principals and leaders to our team, we are better equipped to guide customers through complex modernization with tailored roadmaps and measurable outcomes. This is just the beginning as we look to expand our smart solution offerings into even more industries in the future.”
Caylent’s commitment to AWS and AI innovation is underscored by its recent accolades, including being named AWS Migration Consulting Partner of the Year, GenAI Industry Solution Partner of the Year, and Industry Partner of the Year – Financial Services in 2024. The company’s services encompass migrations, modernization, custom software development, and generative AI, with an AI-enabled delivery methodology aimed at accelerating customer impact.
Also Read:
- SoftServe and AWS Forge Strategic Alliance for Accelerated Cloud and AI Adoption in Enterprises
- AWS Bolsters Generative AI Initiatives with Significant Investment in Innovation Center
Caylent is showcasing these new solutions at booth #552 at the AWS Summit New York City.
